{
     "PMID": "22776965",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20130423",
     "LR": "20121010",
     "IS": "1875-8908 (Electronic) 1387-2877 (Linking)",
     "VI": "32",
     "IP": "2",
     "DP": "2012",
     "TI": "Early increases in soluble amyloid-beta levels coincide with cholinergic degeneration in 3xTg-AD mice.",
     "PG": "267-72",
     "LID": "10.3233/JAD-2012-100732 [doi]",
     "AB": "Accumulation of amyloid-beta peptides (Abeta) and cholinergic degeneration are hallmarks of Alzheimer's disease (AD). In a triple transgenic mouse model of AD (3xTg-AD), soluble Abeta42 levels were detected in the septum by 2 months of age, reaching their highest levels at 3-6 months and decreasing at 12 months. Deficits in the number of septal cholinergic neurons and the length of hippocampal cholinergic axons were observed starting at 4 months in 3xTg-AD mice. Our results show that septal Abeta and septohippocampal cholinergic pathology in 3xTg-AD mice occur at an early stage of disease.",
     "FAU": [
          "Girao da Cruz, M Teresa",
          "Jordao, Jessica",
          "Dasilva, Kevin A",
          "Ayala-Grosso, Carlos A",
          "Ypsilanti, Athena",
          "Weng, Ying-Qi",
          "Laferla, Frank M",
          "McLaurin, Joanne",
          "Aubert, Isabelle"
     ],
     "AU": [
          "Girao da Cruz MT",
          "Jordao J",
          "Dasilva KA",
          "Ayala-Grosso CA",
          "Ypsilanti A",
          "Weng YQ",
          "Laferla FM",
          "McLaurin J",
          "Aubert I"
     ],
     "AD": "Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Biological Sciences, Brain Sciences, Toronto, ON, Canada.",
     "LA": [
          "eng"
     ],
     "GR": [
          "FRN 81125/Canadian Institutes of Health Research/Canada",
          "FRN 93603/Canadian Institutes of Health Research/Canada"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "J Alzheimers Dis",
     "JT": "Journal of Alzheimer's disease : JAD",
     "JID": "9814863",
     "RN": [
          "0 (Amyloid beta-Peptides)"
     ],
     "SB": "IM",
     "MH": [
          "Alzheimer Disease/*metabolism/pathology",
          "Amyloid beta-Peptides/*metabolism",
          "Animals",
          "Axons/metabolism/pathology",
          "Cholinergic Neurons/metabolism/*pathology",
          "Hippocampus/*metabolism/pathology",
          "Mice",
          "Mice, Transgenic",
          "Septum of Brain/*metabolism/pathology"
     ],
     "EDAT": "2012/07/11 06:00",
     "MHDA": "2013/04/24 06:00",
     "CRDT": [
          "2012/07/11 06:00"
     ],
     "PHST": [
          "2012/07/11 06:00 [entrez]",
          "2012/07/11 06:00 [pubmed]",
          "2013/04/24 06:00 [medline]"
     ],
     "AID": [
          "FP63525607H9W1K2 [pii]",
          "10.3233/JAD-2012-100732 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Alzheimers Dis. 2012;32(2):267-72. doi: 10.3233/JAD-2012-100732.",
     "term": "hippocampus"
}